603368.SH
柳药集团
SSE · Healthcare · Medical - Distribution · CN
CNY 15.74
−0.88%Sep 1, 2026, 10:12 UTC
Liuzhou Pharmaceutical Group announced its first-half 2026 results: revenue of 10.526 billion yuan, up 2.19% year-on-year, and net profit attributable to shareholders of 369 million yuan, down 14.00% year-on-year.
Source: